Related references
Note: Only part of the references are listed.Asymptomatic hypoxia in COVID-19 is associated with poor outcome
Philippe Brouqui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients
Savino Spadaro et al.
CRITICAL CARE (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia
Wanhua Guan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?
Armando Rojas et al.
INFLAMMATION RESEARCH (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters
Changzheng Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease
Sijia Liu et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)
Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
Guohui Fan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers
Elena Dozio et al.
JOURNAL OF CLINICAL MEDICINE (2020)
RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?
Mohsen Kerkeni et al.
MEDICAL HYPOTHESES (2020)
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan
Yu Shi et al.
CRITICAL CARE (2020)
Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study
Matthieu Jabaudon et al.
SCIENTIFIC REPORTS (2018)
RAGE inhibition reduces acute lung injury in mice
Raiko Blondonnet et al.
SCIENTIFIC REPORTS (2017)
Is Acute Respiratory Distress Syndrome a Preventable Disease?
Hemang Yadav et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Elevated Plasma Levels of sRAGE Are Associated With Nonfocal CT-Based Lung Imaging in Patients With ARDS A Prospective Multicenter Study
Segolene Mrozek et al.
CHEST (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
Giacomo Bellani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome
Matthieu Jabaudon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study
Matthieu Jabaudon et al.
PLOS ONE (2015)
Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
Rodrigo M. Narvaez-Rivera et al.
BMC INFECTIOUS DISEASES (2012)
Opposing Roles of Membrane and Soluble Forms of the Receptor for Advanced Glycation End Products in Primary Respiratory Syncytial Virus Infection
Allison L. Miller et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients
Matthieu Jabaudon et al.
CRITICAL CARE MEDICINE (2011)
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
Ravichandran Ramasamy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia
Marieke A. D. van Zoelen et al.
VIROLOGY (2009)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
sRAGE is elevated in septic patients and associated with patients outcome
Christian Bopp et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology
Tapan K. Mukherjee et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2008)
Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
C. S. Calfee et al.
THORAX (2008)
Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation
Carolyn S. Calfee et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
T Uchida et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
An introduction to ROC analysis
Tom Fawcett
PATTERN RECOGNITION LETTERS (2006)
Receptor for advanced glycation end-products is a marker of type I lung alveolar cells
M Shirasawa et al.
GENES TO CELLS (2004)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)